In order to sustain a successful, state-wide multi-site clinical trials network, each participating hospital appoints a Site Director. While executive level communication is maintained through Board representatives, CTN2 routinely works with each participating institution's Site Director as the lead on conduct of clinical trials. CTN2 develops working practice guidelines with each participating institution, customized to each institution's particular requirements, policies and environments. CTN2's site liaison and the Site Directors take the lead in developing and implementing those standards and operating procedures to facilitate prompt compliant and effective administration of clinical trials. The Site Director is also regularly consulted on potential and pending clinical trials in the pipeline. The Site Director is the main administrative contact for the TN-EDW data transfer facilitation, and inevitably a key person in the hospital on deploying TN-EDW as a tool for researchers.